Monson Nancy L, Brezinschek Hans-Peter, Brezinschek Ruth I, Mobley Angela, Vaughan Gwen K, Frohman Elliot M, Racke Michael K, Lipsky Peter E
Department of Neurology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
J Neuroimmunol. 2005 Jan;158(1-2):170-81. doi: 10.1016/j.jneuroim.2004.04.022.
To determine whether cerebrospinal fluid (CSF) B cells exhibit clonal expansion in patients recently diagnosed with multiple sclerosis (MS). CSF B cell clonal expansion was detected early in the disease process. Evidence of receptor revision was present in at least one MS patient who had been recently diagnosed with MS. Targeting of mutations to RGYW/WRCY motifs within CDRs was nominally observed in the CSF B cell clones despite the high mutational frequencies (MF). These observations are consistent with the presence of intense specific B cell stimulation and expansion in the CNS of MS patients early in the disease process.
为了确定在近期诊断为多发性硬化症(MS)的患者中,脑脊液(CSF)B细胞是否表现出克隆性扩增。在疾病过程早期检测到脑脊液B细胞克隆性扩增。在至少一名近期诊断为MS的患者中存在受体编辑的证据。尽管突变频率(MF)很高,但在脑脊液B细胞克隆中名义上观察到CDR内的RGYW/WRCY基序的突变靶向。这些观察结果与疾病过程早期MS患者中枢神经系统中强烈的特异性B细胞刺激和扩增的存在一致。